Terms: = Breast cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E
830 results:
1. Study on the differential diagnosis of benign and malignant breast lesions using a deep learning model based on multimodal images.
Du Y; Wang D; Liu M; Zhang X; Ren W; Sun J; Yin C; Yang S; Zhang L
J Cancer Res Ther; 2024 Apr; 20(2):625-632. PubMed ID: 38687933
[TBL] [Abstract] [Full Text] [Related]
2. Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic breast cancer Treated With Abemaciclib: Data From the SCRUM-Japan cancer Genome Screening Project.
Hattori M; Serelli-Lee V; Naito Y; Yamanaka T; Yasojima H; Nakamura R; Fujisawa T; Imai M; Nakamura Y; Bando H; Kawaguchi T; Yoshino T; Iwata H
JCO Precis Oncol; 2024 Apr; 8():e2300647. PubMed ID: 38635933
[TBL] [Abstract] [Full Text] [Related]
3. A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants.
Kim JJ; Kim DJ; Nam EJ; Song KE; Ham JY; Kim YK; Lee NY
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623660
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive Transcriptomic Analysis of EWSR1::WT1 Targets Identifies CDK4/6 Inhibitors as an Effective Therapy for Desmoplastic Small Round Cell Tumors.
Magrath JW; Sampath SS; Flinchum DA; Hartono AB; Goldberg IN; Boehling JR; Savkovic SD; Lee SB
Cancer Res; 2024 May; 84(9):1426-1442. PubMed ID: 38588409
[TBL] [Abstract] [Full Text] [Related]
5. Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells.
Shuaib M; Chaudhri S; Kumar S
Biomol Concepts; 2024 Jan; 15(1):. PubMed ID: 38525814
[TBL] [Abstract] [Full Text] [Related]
6. Epigenetic Effects of Resveratrol on Oncogenic Signaling in breast cancer.
Kurzava Kendall L; Ma Y; Yang T; Lubecka K; Stefanska B
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474826
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract] [Full Text] [Related]
8. Mechanism of Erianin anti-triple negative breast cancer based on transcriptomics methods and network pharmacology.
Li M; Zhao Y; Li H; Kang S; Deng X; Sheng M
Aging (Albany NY); 2024 Feb; 16(3):2848-2865. PubMed ID: 38329441
[TBL] [Abstract] [Full Text] [Related]
9. Survival trends and patient characteristics between 2004 and 2016 for breast cancer in Japan based on the National Clinical Database-breast cancer Registry.
Iwamoto T; Kumamaru H; Niikura N; Sagara Y; Miyashita M; Konishi T; Sanuki N; Tanakura K; Nagahashi M; Hayashi N; Yoshida M; Watanabe C; Kinukawa N; Toi M; Saji S
Breast Cancer; 2024 Mar; 31(2):185-194. PubMed ID: 38319565
[TBL] [Abstract] [Full Text] [Related]
10. A novel disulfidptosis-related lncRNA signature for predicting prognosis and potential targeted therapy in hepatocellular carcinoma.
Zhang H; Wang J; Yang M
Medicine (Baltimore); 2024 Jan; 103(4):e36513. PubMed ID: 38277541
[TBL] [Abstract] [Full Text] [Related]
11. Trps1 predicts poor prognosis in advanced high grade serous ovarian carcinoma.
Wang X; Sun J; Liu Y; Lin Z; Jiang X; Ye Y; Lv C; Lian X; Xu W; Luo S; Liao S; Chen Z; Wang S
Int J Cancer; 2024 May; 154(9):1639-1651. PubMed ID: 38212905
[TBL] [Abstract] [Full Text] [Related]
12. Anti-breast cancer activity of biosynthesized selenium nanoparticles using Bacillus coagulans supernatant.
Khaledizade E; Tafvizi F; Jafari P
J Trace Elem Med Biol; 2024 Mar; 82():127357. PubMed ID: 38103517
[TBL] [Abstract] [Full Text] [Related]
13. Troponin T1 silencing inhibits paclitaxel resistance and the development of breast cancer via suppressing rat sarcoma virus/rapidly accelerated fibrosarcoma 1 pathway.
Zhu T; Zhou P; Yang L; Fang X; Zhi X
Environ Toxicol; 2024 Apr; 39(4):2064-2076. PubMed ID: 38095131
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants.
Schwartz CJ; Khorsandi N; Blanco A; Mukhtar RA; Chen YY; Krings G
Breast Cancer Res Treat; 2024 Feb; 204(1):171-179. PubMed ID: 38091153
[TBL] [Abstract] [Full Text] [Related]
15. Nuclear isoform of RAPH1 interacts with FOXQ1 to promote aggressiveness and radioresistance in breast cancer.
Liu Q; Cao Y; Wei X; Dong H; Cui M; Guan S; Liu B; Wang X; Xing P
Cell Death Dis; 2023 Dec; 14(12):803. PubMed ID: 38062011
[TBL] [Abstract] [Full Text] [Related]
16. Progestins and breast cancer hallmarks: The role of the ERK1/2 and JNK pathways in estrogen receptor positive breast cancer cells.
Louw-du Toit R; Simons M; Africander D
J Steroid Biochem Mol Biol; 2024 Mar; 237():106440. PubMed ID: 38048919
[TBL] [Abstract] [Full Text] [Related]
17. Evaluation of tumor-infiltrating lymphocytes and mammographic density as predictors of response to neoadjuvant systemic therapy in breast cancer.
Landén AH; Chin K; Kovács A; Holmberg E; Molnar E; Stenmark Tullberg A; Wärnberg F; Karlsson P
Acta Oncol; 2023 Dec; 62(12):1862-1872. PubMed ID: 37934084
[TBL] [Abstract] [Full Text] [Related]
18. The chromatin architectural regulator SND1 mediates metastasis in triple-negative breast cancer by promoting CDH1 gene methylation.
Zhang H; Gao M; Zhao W; Yu L
Breast Cancer Res; 2023 Oct; 25(1):129. PubMed ID: 37885030
[TBL] [Abstract] [Full Text] [Related]
19. Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
Augustin RC; Newman S; Li A; Joy M; Lyons M; Pham MP; Lucas P; Smith K; Sander C; Isett B; Davar D; Najjar YG; Zarour HM; Kirkwood JM; Luke JJ; Bao R
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37857525
[TBL] [Abstract] [Full Text] [Related]
20. KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer.
Yao L; Hao Q; Wang M; Chen Y; Cao H; Zhang Q; Yu K; Jiang Y; Shao Z; Zhou X; Xu Y
Oncogene; 2023 Nov; 42(47):3514-3528. PubMed ID: 37845393
[TBL] [Abstract] [Full Text] [Related]
[Next]